Drug Trial Radar · NCT02585934
Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study
Last checked: Nov 19, 2026Latest source record: Dec 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,315
Actual
Start
Oct 2015
Primary completion
Sep 2017
Study completion Sep 2017
Sponsor
- Lead sponsor
- Axovant Sciences Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 26, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study seeks to confirm a demonstrated treatment effect of intepirdine (RVT-101) as an adjunctive therapy to donepezil for the treatment of subjects with Alzheimer's disease.
Conditions
- Alzheimer's Disease
Interventions
RVT-101Drug
once daily, oral, 35 mg tablets
PlaceboDrug
once daily, oral, pill manufactured to match RVT-101 35 mg tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Alzheimer's Disease Assessment Scale - Cognitive Subscale 11 Items (ADAS-Cog-11) Score Change From Baseline to Week 24Time frame: Baseline, 24 weeks
- Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL) Score Change From Baseline to Week 24Time frame: Baseline, 24 weeks
Locations
197 sites in 19 countries. Site status is shown where the registry gives one.
US112
Phoenix, Arizona
US220
Tucson, Arizona
US168
Encino, California
US117
Fullerton, California
US214
Los Angeles, California
US189
Pasadena, California
US096
Rancho Mirage, California
US0195
Santa Ana, California
US016
Simi Valley, California
US106
Temecula, California
US179
Hamden, Connecticut
US171
Norwich, Connecticut
US088
Atlantis, Florida
US007
Brooksville, Florida
US002
Hallandale, Florida
US140
Hialeah, Florida
US216
Miami, Florida
US110
Miami, Florida
US172
North Palm Beach, Florida
US003
Orlando, Florida
US256
Pensacola, Florida
US037
Tampa, Florida
US042
Tampa, Florida
US004
The Villages, Florida
US048
Atlanta, Georgia
US046
Atlanta, Georgia
US217
Columbus, Georgia
US111
Baton Rouge, Louisiana
US095
Shreveport, Louisiana
US116
Newton, Massachusetts
US174
Quincy, Massachusetts
US144
Hattiesburg, Mississippi
US094
Las Vegas, Nevada
US135
Berlin, New Jersey
US197
Lawrenceville, New Jersey
US215
Mount Arlington, New Jersey
US057
Paterson, New Jersey
US209
Toms River, New Jersey
US036
West Long Branch, New Jersey
US001
Albany, New York
Showing 40 of 197 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.